High prevalence of myocardial perfusion abnormalities on positron emissiontomography in asymptomatic persons with a parent or sibling with coronary artery disease
S. Sdringola et al., High prevalence of myocardial perfusion abnormalities on positron emissiontomography in asymptomatic persons with a parent or sibling with coronary artery disease, CIRCULATION, 103(4), 2001, pp. 496-501
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-We hypothesized that asymptomatic persons with a parent or sibli
ng with coronary artery disease (CAD) have myocardial perfusion defects on
positron emission tomography (PET) as markers of early CAD.
Methods and Results-After medical and family histories were recorded, 90 su
bjects underwent rest-dipyridamole cardiac PET perfusion imaging, including
18 index cases (a subject with CAD documented by PET and arteriography), 3
2 asymptomatic adults without known CAD who had a parent or sibling with CA
D among these index cases, 30 asymptomatic subjects with comparable coronar
y risk factors without CAD or a family history of CAD, and 10 volunteer con
trol subjects with no risk factors and no family history. PET perfusion ima
ges were quantified with automated software for size of abnormalities as pe
rcent of the cardiac image outside 95% CIs of normal controls and for sever
ity as the lowest quadrant average relative activity. Of asymptomatic subje
cts with a parent or sibling with CAD (first-degree relatives), 50% had dip
yridamole-induced myocardial perfusion defects that involved greater than o
r equal to5% of the cardiac image outside normal 95% CIs with or without ot
her risk factors. The size of perfusion defects was larger in first-degree
relatives than in control subjects (11+/-13% versus 1+/-1%, P=0.02) and lar
ger than in asymptomatic subjects with comparable risk factors but no famil
y history of CAD (11+/-13% versus 5+/-6%, P=0.02).
Conclusions-This study documents the presence of quantitative, statisticall
y significant, dipyridamole-induced myocardial perfusion abnormalities on P
ET in 50% of asymptomatic persons with a parent or sibling with CAD, indepe
ndent of other risk factors, indicating preclinical coronary atherosclerosi
s.